iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding iSpecimen Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 13 | 14 | +1 |
| Shares | 385.2K | 391.6K | +6.34K (+1.6%) |
| Value | $238.5K | $195.7K | −$42.9K (−18.0%) |
New holders (4)
Institutions that held iSpecimen Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 38,809 | $19.4K | 0.00% |
| Millennium Management LLC | 21,488 | $10.8K | 0.00% |
| Advisor Group Holdings, Inc. | 15,516 | $7.77K | 0.00% |
| Renaissance Technologies LLC | 10,692 | $5.00K | 0.00% |
Sold out (3)
Institutions that held iSpecimen Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 22,770 | $14.1K |
| HRT Financial LP | 13,380 | $8.00K |
| JPMorgan Chase & Co | 5 | $3 |